[Federal Register Volume 89, Number 133 (Thursday, July 11, 2024)]
[Notices]
[Page 56848]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-15252]


 ========================================================================
 Notices
                                                 Federal Register
 ________________________________________________________________________
 
 This section of the FEDERAL REGISTER contains documents other than rules 
 or proposed rules that are applicable to the public. Notices of hearings 
 and investigations, committee meetings, agency decisions and rulings, 
 delegations of authority, filing of petitions and applications and agency 
 statements of organization and functions are examples of documents 
 appearing in this section.
 
 ========================================================================
 

  Federal Register / Vol. 89, No. 133 / Thursday, July 11, 2024 / 
Notices  

[[Page 56848]]



DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-12-2024]


Foreign-Trade Zone (FTZ) 49; Authorization of Production 
Activity; Merck Sharp & Dohme LLC; (Pharmaceutical Products for 
Research and Development); Rahway, New Jersey

    On March 8, 2024, Merck Sharp & Dohme LLC submitted a notification 
of proposed production activity to the FTZ Board for its facility 
within Subzone 49Y, in Rahway, New Jersey.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (89 FR 19295, March 18, 2024). On July 
8, 2024, the applicant was notified of the FTZ Board's decision that no 
further review of the activity is warranted at this time. The 
production activity described in the notification was authorized, 
subject to the FTZ Act and the FTZ Board's regulations, including 
section 400.14.

    Dated: July 8, 2024.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2024-15252 Filed 7-10-24; 8:45 am]
BILLING CODE 3510-DS-P